Pubblicazioni

A comment from SIGIS, SIE and SIAMS: "Puberty blockers in transgender adolescents-a matter of growing evidence and not of ideology"

J Ristori, G Motta, M C Meriggiola, C Bettocchi, C Crespi, M Falcone, F Lombardo, M Maggi, G Morelli, A M Colao, A M Isidori, A D Fisher

J Endocrinol Invest . 2023 Sep 11. doi: 10.1007/s40618-023-02173-6.
https://pubmed.ncbi.nlm.nih.gov/37695460/

Standards of Care for the Health of Transgender and Gender Diverse People, Version 8

Coleman E. et al.

International Journal of Transgender Health 2022, VOL. 23, NO. S1, S1–S258 https://doi.org/10.1080/26895269.2022.2100644

SIGIS–SIAMS–SIE position statement of gender affirming hormonal treatment in transgender and non‑binary people

A. D. Fisher, G. Senofonte, C. Cocchetti, G. Guercio, V. Lingiardi, M. C. Meriggiola, M. Mosconi, G. Motta, J. Ristori, A. M. Speranza, M. Pierdominici, M. Maggi, G. Corona, F. Lombardo

 J Endocr Invest 2022 Mar;45(3):657-673. doi: 10.1007/s40618-021-01694-2. Epub 2021 Oct 22

European Society for Sexual Medicine Position Statement "Assessment and Hormonal Management in Adolescent and Adult Trans People, With Attention for Sexual Function and Satisfaction".

T'Sjoen G, Arcelus J, De Vries ALC, Fisher AD, Nieder TO, Özer M, Motmans J.

J Sex Med. 2020 Apr;17(4):570-584. doi: 10.1016/j.jsxm.2020.01.012.

Medical treatment in gender dysphoric adolescents endorsed by SIAMS-SIE-SIEDP-ONIG.

Fisher AD, Ristori J, Bandini E, Giordano S, Mosconi M, Jannini EA, Greggio NA, Godano A, Manieri C, Meriggiola C, Ricca V; Italian GnRH analogs study ONIG group, Dettore D, Maggi M.

J Endocrinol Invest. 2014 Jul;37(7):675-87. doi: 10.1007/s40618-014-0077-6